Reduction in oral corticosteroid use with mometasone furoate dry powder inhaler improves health-related quality of life in patients with severe persistent asthma.
about
Mometasone furoate in the management of asthma: a reviewAsthma outcomes: quality of lifeNew anti-inflammatory therapies and targets for asthma and chronic obstructive pulmonary disease.An evaluation of the cost-effectiveness of omalizumab for the treatment of severe allergic asthma.Stepping down the dose of inhaled corticosteroids for adults with asthma.Economic assessment of adjustable maintenance treatment with budesonide/formoterol in a single inhaler versus fixed treatment in asthma.
P2860
Reduction in oral corticosteroid use with mometasone furoate dry powder inhaler improves health-related quality of life in patients with severe persistent asthma.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Reduction in oral corticostero ...... with severe persistent asthma.
@en
Reduction in oral corticostero ...... with severe persistent asthma.
@nl
type
label
Reduction in oral corticostero ...... with severe persistent asthma.
@en
Reduction in oral corticostero ...... with severe persistent asthma.
@nl
prefLabel
Reduction in oral corticostero ...... with severe persistent asthma.
@en
Reduction in oral corticostero ...... with severe persistent asthma.
@nl
P2860
P356
P1433
P1476
Reduction in oral corticostero ...... with severe persistent asthma.
@en
P2093
Nancy Kline Leidy
Richard Gower
P2860
P304
P356
10.1081/JAS-120018708
P407
P577
2003-06-01T00:00:00Z